FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
01/02/2024
Back to search
Official data from USPTO
BIOSYNEX
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
BIOSYNEX
ST13
US500000079313560Class
1, 5, 10, 42
Filing
79313560
Registration
7159430
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
44
Latest update
01/02/2024
Trademark type
Word
Nice classes
1, 5, 10, 42
Filing date
05/11/2021
Registration date
09/12/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
09/12/2023
Last transaction
09/12/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
03
Owner location
FR
Examiner
SEVERSON, JUSTIN
Law office
M20
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
BIOSYNEX
Representatives
JOSEPH SOFER IPSILON USA, LLP
Technical classification
Nice Classes
Class 1Class 5Class 10Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemical products for use in industry and science; chemical reagentsother than for medical or veterinary purposes ; diagnostic preparations other than for medical or veterinary purposes ; Chemically-treated nonmedical strips for chemical and biological analysis
Class 5
Chemical and biological reagents and products for medical or veterinary purposesreagents for use in diagnostic testsreagents for use in diagnostic tests for screening purposesreagents for medical usechemical reagents for medical purposesdiagnostic biomarker reagents for medical use; immunoassay reagents for medical usereagent paper for medical purposes; reagents and preparations for pregnancy testschemical preparations for use in DNA medical analysis and Chemicals for use in RNA analysis for medical purposes; diagnostic products for medical purposesmedical diagnostic test strips for the detection of coronavirusvirusesbacteria or parasite for medical purposesmedical diagnostic test strips for measuring blood glucose levelsmedical diagnostic test strips for measuring cholesterol levelstriglyceridescardiac markers or any other biomedical marker; testing kits comprised of medical diagnostic agentspreparations and substances for medical purposes for use in disease detectioncoronavirusHIVrespiratory viral infectionshepatitis Bhepatitis Cinfluenzainfectious mononucleosisdenguenorovirusrotavirusadenovirusurinary tract infectionscolorectal cancerC-reactive proteincyclic citrullinated peptidepremature rupture of the fetal membranesChlamydia trachomatishelicobacter pylorilegionnaire's diseasepneumoniasyphilistetanusmalariamycosesherpesrubellawhooping coughLyme disease; preparations and substances for medical purposes for use in drugs detectionamphetaminesbuprenorphinecocainecotininemethadonefentanylmethamphetaminesmorphineoxycodonephencyclidinecannabistramadol; pregnancy test kits and ovulation test kits for home use; diagnostic test kits comprised of medical diagnosticfor medical purposes for the detection of coronavirusvirusesbacteria or parasite for medical purposes; in vitro diagnostic preparations for medical use for the detection of coronavirusvirusesbacteria or parasite for medical purposes; self-testing diagnostic kits comprising in vitro diagnostic agentspreparations and substances for medical purposes for the detection of coronavirusvirusesbacteria or parasite for medical purposes; medical diagnostic test kits for the detection of coronavirusvirusesbacteria or parasite for medical purposes; medical diagnostic reagents and assays for testing of body fluids for the detection of coronavirusvirusesbacteria or parasite for medical purposes; medical diagnostic reagents; chemical reagents for medical or veterinary purposes
Class 10
Diagnostic apparatus for medical purposesblood testing apparatus; genetic testing apparatus for medical purposes; diagnostic test readers for medical use; medical diagnostic apparatus for testing DNA and RNA samples; medical apparatus and instrumentsinstruments for loop-mediated isothermal amplification for medical purposes; quantitative Polymerase Chain Reaction PCR instruments for medical use; real-time polymerase chain reaction (PCR) instruments for medical purposes; testing instruments for medical diagnostic purposesfor the detection of coronavirusvirusesbacteria or parasite for medical purposes; capillary tubes for samples; medical specimen cups; specimen cup holders; apparatus for taking body fluid samplesmedical devices for obtaining body fluid samples; gloves for medical purposessanitary masks for medical purposesthermometers for medical usechemically activated hot and cold gel packs for medical purposes; cooling patches for medical purposes; Ice bags for medical purposesfirst-aid cooling patcheselastic bandagesBandages for orthopaedic purposes
Class 42
Chemical analysis and research services; biological research; bacteriological research; chemical research; pharmaceutical research services; calibration of devices employed in such services
Publications
History of USPTO decisions and trademark events.
44 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
12/12/2023
FIMP
FINAL DISPOSITION PROCESSED
12/12/2023
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
12/12/2023
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
09/12/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
09/12/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06/27/2023
PUBO
PUBLISHED FOR OPPOSITION
06/27/2023
GPNX
NOTIFICATION PROCESSED BY IB
06/26/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
06/07/2023
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
06/07/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
06/07/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/24/2023
XAEC
EXAMINER'S AMENDMENT ENTERED
05/24/2023
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
05/24/2023
GNEA
EXAMINERS AMENDMENT E-MAILED
05/24/2023
CNEA
EXAMINERS AMENDMENT -WRITTEN
05/24/2023
JURT
JURISDICTION RESTORED TO EXAMINING ATTORNEY
04/28/2023
EXPI
EX PARTE APPEAL-INSTITUTED
03/09/2023
EXAF
EXPARTE APPEAL RECEIVED AT TTAB
03/09/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/07/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/06/2023
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
03/06/2023
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
12/11/2022
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
11/23/2022
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
11/23/2022
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
09/09/2022
GNFR
FINAL REFUSAL E-MAILED
09/09/2022
CNFR
FINAL REFUSAL WRITTEN
09/09/2022
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
08/23/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
08/23/2022
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
08/23/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/09/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/08/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/08/2022
RFNT
REFUSAL PROCESSED BY IB
02/27/2022
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
02/07/2022
RFRR
REFUSAL PROCESSED BY MPU
02/07/2022
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
01/20/2022
CNRT
NON-FINAL ACTION WRITTEN
01/19/2022
DOCK
ASSIGNED TO EXAMINER
01/19/2022
MAFR
APPLICATION FILING RECEIPT MAILED
06/29/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/23/2021
SDRC
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
06/17/2021
Continuous trademark protection
Get notified about every new filing that threatens BIOSYNEX or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.